Orthokeratology Market Size, Share, Analysis, Trends, Growth Report, 2030

Orthokeratology Industry Prospective:

The global orthokeratology market size was worth around USD 730.6 million in 2022 and is predicted to grow to around USD 1205.6 million by 2030 with a compound annual growth rate (CAGR) of roughly 6.46% between 2023 and 2030.

Request Free Sample

Orthokeratology Market: Overview

Orthokeratology is also known as ortho-K. It is a non-surgical and non-invasive medical procedure in which specially designed lenses known as ortho-k are fitted in a patient’s eyes. The ortho-k lens is not permanently implanted but temporarily. It helps in reshaping the cornea or improving vision. Once the end goal is achieved, the lens implants are removed. In medical terms, it can be compared to dental braces. The primary function of ortho-k procedures is to improve myopia which causes near-sightedness. Although there are several other ways to treat myopia such as Laser-Assisted In Situ Keratomileusis (LASIK), most alternate options are surgical procedures which is one of the main reasons for higher preference for ortho-K in countries with higher patient awareness and greater access to non-invasive medical procedures. However, ortho-k lenses also have certain specific drawbacks associated with them which are currently acting as growth barriers. During the forecast period, the orthokeratology industry is expected to grow at a steady momentum.

Key Insights:

• As per the analysis shared by our research analyst, the global orthokeratology market is estimated to grow annually at a CAGR of around 6.46% over the forecast period (2023-2030)
• In terms of revenue, the global orthokeratology market size was valued at around USD 730.6 million in 2022 and is projected to reach USD 1205.6 million, by 2030.
• The orthokeratology market is projected to grow at a significant rate due to the rising cases of myopia
• Based on indication segmentation, myopia was predicted to show maximum market share in the year 2022
• Based on product type segmentation, overnight ortho-k lenses was the leading segment in 2022
• On the basis of region, North America was the leading revenue generator in 2022

Orthokeratology Market: Growth Drivers

Rising cases of myopia to drive market growth

The global orthokeratology market is expected to grow owing to the rising number of people with near-sightedness or myopia. It is a common sight-related medical condition causing objects placed near the eyes to appear clear but the ones placed farther away appear blurred. The condition starts to develop during childhood or adolescence and tends to become stable when a person reaches the age of 20 to 40 years. Myopia is caused when the condition or shape of the cornea causes inaccurate focusing of the light that is passing through the eye. In some cases, the refractive error can be caused by the eye shape itself. Several risk factors are associated with the condition including genetics, environmental conditions, screen time, and prolonged close-up activities. As per reports published by the International Myopia Institute around 30% of the world’s population is currently myopic and the statistics are expected to reach 50% by 2050.

Growing demand for non-invasive medical procedures to create a higher consumption rate

Orthokeratology is a non-invasive medical procedure using customized ortho-k lenses to improve the shape of the cornea or sight issues. Ortho-K lenses are typically to be overnight when the patient is sleeping. They are rigid and gas-permeable lenses that can support cornea reshaping while allowing oxygen entry into the eyes keeping them healthy. Other cornea-correcting medical procedures typically involve some form of surgery and there is a growing demand for non-invasive medical procedures especially for extremely sensitive body parts such as the eyes. The growing solution awareness as well as the comfort offered by ortho-k lenses is projected to drive global orthokeratology market growth to new heights during the forecast period.

Orthokeratology Market: Restraints

Complication risks associated with ortho-k lenses could restrict market growth

The demand for ortho-k medical processes may be restricted owing to the several risks associated with the lenses. For instance, some of these risks are similar to the ones when normal lenses are worn including the risk of eye infection. Children are more vulnerable to these risks if they do not practice good contact lenses and clean hand hygiene. In addition to this, several people across the globe are not comfortable with touching the eye or the area around it directly. Using ortho-k lenses requires some amount of training and a large segment of potential consumers may be unwilling to use these lenses. In case the patient is unable to adhere to wearing ortho-k lenses every day until prescribed, the results may not be evident leading to patient non satisfaction with the treatment further limiting growth in the ortho-k industry.

Orthokeratology Market: Opportunities

Growing research and development to improve lens efficiency to create growth opportunities

The orthokeratology industry growth is projected to witness excellent growth opportunities resulting from the ongoing extensive research and development to understand and improve the overall lens efficiency in dealing with incorrect cornea structure or myopia. In July 2023, the Review of Cornea & Contact Lenses (RCCL) published a report stating that ortho-K was more effective in children as compared to adults. The research concluded that younger children registering early onset of myopia when treated with ortho-k lenses have an excellent chance of curbing condition progression. Another published research finding by RCCL during the same month concluded that combining ortho-k treatment with atropine can temporarily improve myopia slowdown. However, more research and studies are needed to reach a final conclusion. The rising number of new solutions with higher efficiency will also help in delivering new expansion avenues to the orthokeratology industry players. Recently, GP Specialists, a leading manufacturer of ortho-k products, launched iSee Ortho-k lens, an advanced ortho-k lens design. The lens is influenced by the United States Food and Drug Administration (FDA)-approved FARGO ortho-k contact lens.

In September 2021, Scotlens, a contact lens-specializing company, announced a partnership with Avizor. The companies jointly launched the ‘unboxing experience’ with the intention of creating mass public awareness about ortho-k night lenses. The companies expected to create patient excitement upon receiving their ortho-k lenses.

Orthokeratology Market: Challenges

Growing demand for alternate solutions to challenge market growth

Several other medical procedures are available in the market to treat myopia and improve cornea structure. For instance, the most simple and widely prevalent solution is wearing optician or medically-recommended eyeglasses. These medical instruments are highly effective and do not require the patient to undergo any form of surgical or non-surgical medical procedure. A report by The Vision Council claimed that nearly 64% of all adults wore some form of eyeglasses while at least 11% were accustomed to wearing contact lenses. There is significant demand for certain surgical procedures as well including LASIK. These factors are likely to create challenges in the orthokeratology industry.

Orthokeratology Market: Segmentation

The global orthokeratology market is segmented based on indication, distribution channel, product type, and region.

Based on indication, the global market segments are hypermetropia, presbyopia, myopia, and astigmatism. In 2022, the highest growth was observed in the myopia segment which led to over 40.1% of the total revenue. The rising number of people with myopia are the leading segmental drivers. An increase in desk jobs leading to more screen time on laptops and computers along with growing addiction to social media and consistent use of some form of digital tool such as tablets, smartphones, and other devices are some of the associated risk factors that could trigger myopia. The growing prevalence of diabetes is another crucial risk factor. As per research, diabetic eye disease may develop within 5 to 10 years of contracting the condition.

Based on distribution channel, the global orthokeratology market divisions are hospitals, ophthalmology clinics, optometry clinics, and others.

Based on product type, the orthokeratology industry segments are overnight ortho-k lenses and daytime ortho-k lenses. The most dominant segment was overnight ortho-k lenses as it held control over 94.5% of the total segmental share. These lenses are mostly designed to be worn when sleeping. People who are uncomfortable with wearing lenses or are into extreme sports may be unable to wear daytime ortho-k lenses.

Orthokeratology Market: Report Scope

Orthokeratology Market: Regional Analysis

North America to register the highest growth rate during the assessment timeframe

The global orthokeratology market is expected to witness the highest growth rate in North America. It controlled around 37.52% of the final global revenue in 2022. Factors driving regional growth are higher product awareness and a rising number of ortho-k lens providers in addition to an increasing number of new product launches. In November 2021, Johnson & Johnson Vision, a leading player in eye health, announced that it had received FDA approval for the sale of ACUVUE® Abiliti™ Overnight Therapeutic Lenses meant for managing myopia. These are custom-made lenses and are highly effective in reshaping the cornea. The rising number of myopic patients in the US is expected to benefit from the launch. In May 2021, Euclid Systems Corporation launched the Euclid MAX OrthoK lenses with FDA approval. Asia-Pacific is expected to register higher revenue driven by an increasing number of people with near-sightedness. For instance, in developed countries of Southeast and East Asia, myopia prevalence rate is around 80 to 90% in young adults.

Orthokeratology Market: Competitive Analysis

The global orthokeratology market is led by players like:

• GP Specialists
• Paragon Vision Sciences
• Alpha Corporation
• Euclid Systems Corporation
• Procornea
• Bausch + Lomb
• Brighten Optix
• Art Optical Contact Lens Inc.
• TFOS Orthokeratology
• Menicon
• E&E Optics
• Autek China
• Precilens
• AOK Group
• Gelflex.

The global orthokeratology market is segmented as follows:

By Indication

• Hypermetropia
• Presbyopia
• Myopia
• Astigmatism

By Distribution Channel

• Hospitals
• Ophthalmology Clinics
• Optometry Clinics
• Others

By Product Type

• Overnight Ortho-K Lenses
• Day-Time Ortho-K Lenses

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa